| Affiliation: | 1. Thrombosis Unit Sheba Medical Center, Tel Hashomer, Israel;2. The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;3. Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA;1. Sorbonne University, ACTION Group, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France;2. PERFUSE Study Group, Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States |
